Female Genital Schistosomiasis | NEJM
Perspective from The New England Journal of Medicine — Female Genital Schistosomiasis
Related Articles
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke | NEJM
Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide…
Shared Savings for Nursing Homes — The Potential Role of Institutional Special-Needs Plans | NEJM
Institutional special-needs plans could warrant further investigation as a value-based model for financing care provided to long-stay nursing home residents.
A Monoclonal Antibody to PACAP for Migraine Prevention | NEJM
Targeting pituitary adenylate cyclase–activating polypeptide (PACAP) is a new avenue for treating migraine. The efficacy and safety of intravenous Lu AG09222, a humanized monoclonal antibody…
Doxorubicin plus Trabectedin in Leiomyosarcoma | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Doxorubicin plus Trabectedin in Leiomyosarcoma
September 5, 2024 | NEJM
Image Challenge from the New England Journal of Medicine — September 5, 2024
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus | NEJM
A woman with aggressive refractory systemic lupus erythematosus was treated with a short course of the bispecific antibody teclistamab (anti–B-cell maturation antigen and anti-CD3) and…
Primary Cutaneous Herpes Simplex Virus Infection of the Cheek | NEJM
A 9-year-old girl presented with a 7-day history of a lesion on the left cheek and a 4-day history of fever. Treatment for possible impetigo…
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke | NEJM
Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide…
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke | NEJM
Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide…
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease | NEJM
In four patients with severe autoimmune disease, teclistimab, a bispecific antibody to B-cell maturation antigen and CD3, resulted in autoantibody reduction and clinical response after…